{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:19Z","timestamp":1786996759250,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.semarthrit.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T14:00:57Z","timestamp":1506348057000},"page":"727-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Blau syndrome with good Reponses to Tocilizumab: A case report and focused literature review"],"prefix":"10.1016","volume":"47","author":[{"given":"Li","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanmin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quancheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2017.09.010_bib1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Rose","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semarthrit.2012.12.005","article-title":"Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases","volume":"43","author":"Yao","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","article-title":"Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism","volume":"62","author":"Yasui","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2012.07.028","article-title":"Blau syndrome, clinical and genetic aspects","volume":"12","author":"Sfriso","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib5","first-page":"2504","article-title":"Central nervous system involvement in Blau syndrome: a new feature of the syndrome?","volume":"34","author":"Emaminia","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14737159.2017.1335598","article-title":"The role of genetic testing in epilepsy diagnosis and management","volume":"17","author":"Weber","year":"2017","journal-title":"Expert Rev Molec Diagnost"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib8","first-page":"134106","article-title":"Etanercept-induced myelopathy in a pediatric case of blau syndrome","volume":"2011","author":"Caracseghi","year":"2011","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D31GZ33233","article-title":"Two pediatric cases of Blau syndrome","volume":"15","author":"Glass","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00124743-200002000-00005","article-title":"Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an African-American family","volume":"6","author":"Cuesta","year":"2000","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.24222","article-title":"The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity","volume":"60","author":"Martin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaapos.2011.02.004","article-title":"Uveitis in Blau syndrome from a de novo mutation of the NOD2\/CARD15 gene","volume":"15","author":"Raiji","year":"2011","journal-title":"J AAPOS"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib13","first-page":"463959","article-title":"A new mutation in blau syndrome","volume":"2015","author":"Zeybek","year":"2015","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","article-title":"Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation","volume":"114","author":"Milman","year":"2006","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/keq431","article-title":"Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNFalpha monoclonal antibodies","volume":"50","author":"Sharma","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib16","first-page":"586","article-title":"Sarcoidosis in childhood: report of three cases","volume":"28","author":"Cavalcanti","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/s10165-012-0720-z","article-title":"A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome\/early-onset sarcoidosis","volume":"23","author":"Inoue","year":"2013","journal-title":"Modern Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/art.22509","article-title":"Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15","volume":"56","author":"Becker","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib19","first-page":"1","article-title":"A long-term follow-up of Japanese mother and her daughter with Blau syndrome: effective treatment of anti-TNF inhibitors and useful diagnostic tool of joint ultrasound examination","author":"Otsubo","year":"2014","journal-title":"Modern Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2340\/00015555-2485","article-title":"Diagnosis and treatment of Blau Syndrome\/early-onset sarcoidosis, an autoinflammatory granulomatous disease, in an infant","volume":"96","author":"Arvesen","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10792-015-0135-x","article-title":"Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis","volume":"36","author":"Achille","year":"2016","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib22","first-page":"216056","article-title":"A case of blau syndrome","volume":"2014","author":"Chauhan","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.37776","article-title":"Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis","volume":"65","author":"Simonini","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","article-title":"Adalimumab therapy for refractory childhood uveitis","volume":"17","author":"Bravo-Ljubetic","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib25","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort","volume":"56","author":"Arostegui","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.09.010_bib26","unstructured":"Infevers Registry. [fmf.igh.cnrs.fr\/infevers]."},{"key":"10.1016\/j.semarthrit.2017.09.010_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217302317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217302317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T07:11:11Z","timestamp":1659510671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217302317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0049017217302317"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.010","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blau syndrome with good Reponses to Tocilizumab: A case report and focused literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}